Doxorubicin Hydrochloride Liposome as First-Line Therapy in Treating Older Women With Metastatic Breast Cancer
NCT00960336
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
59
Enrollment
OTHER
Sponsor class
Conditions
Breast Cancer
Interventions
DRUG:
pegylated liposomal doxorubicin hydrochloride
Sponsor
ARCAGY/ GINECO GROUP